BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17127453)

  • 1. Role of B cells in Sjögren's syndrome--from benign lymphoproliferation to overt malignancy.
    Jonsson R; Nginamau E; Szyszko E; Brokstad KA
    Front Biosci; 2007 Jan; 12():2159-70. PubMed ID: 17127453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
    Karnell JL; Mahmoud TI; Herbst R; Ettinger R
    Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Gland Pathology in Sjögren's Syndrome.
    Campos J; Hillen MR; Barone F
    Rheum Dis Clin North Am; 2016 Aug; 42(3):473-83. PubMed ID: 27431349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
    Mavragani CP
    Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome.
    Stott DI; Hiepe F; Hummel M; Steinhauser G; Berek C
    J Clin Invest; 1998 Sep; 102(5):938-46. PubMed ID: 9727062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
    Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
    Front Immunol; 2018; 9():2661. PubMed ID: 30519241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
    Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
    J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
    Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome.
    Abdulahad WH; Kroese FG; Vissink A; Bootsma H
    J Autoimmun; 2012 Aug; 39(1-2):103-11. PubMed ID: 22341852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte subsets in labial salivary gland of Sjogren's syndrome].
    Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):83-8. PubMed ID: 8242827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies.
    Nguyen CQ; Cha SR; Peck AB
    Front Biosci; 2007 Jan; 12():1767-89. PubMed ID: 17127420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
    Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
    J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarization of B effector cells in Sjögren's syndrome.
    Daridon C; Guerrier T; Devauchelle V; Saraux A; Pers JO; Youinou P
    Autoimmun Rev; 2007 Aug; 6(7):427-31. PubMed ID: 17643928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell populations and sub-populations in Sjögren's syndrome.
    Hamza N; Bos NA; Kallenberg CG
    Presse Med; 2012 Sep; 41(9 Pt 2):e475-83. PubMed ID: 22841377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
    Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
    Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the B cells cast with the leading part in the Sjogren's syndrome scenario?
    Pers JO; Youinou P
    Oral Dis; 2014 Sep; 20(6):529-37. PubMed ID: 23837848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
    Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
    J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-lymphocytes govern the pathogenesis of Sjögren's syndrome.
    Youinou P; Saraux A; Pers JO
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2071-7. PubMed ID: 22208653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.